A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment.

NCT01266941 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Inhaled FF 200mcg/GW642444M 25mcg

Sponsor

GlaxoSmithKline